MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis

Postmenopausal women with osteoporosis may also have renal insufficiency. We conducted a post hoc analysis of the ARCH study to determine the efficacy and safety of romosozumab (Romo) vs alendronate (ALN) among patients with different levels of baseline renal function. In ARCH, 4,093 postmenopausal...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Miller, Paul, Cheung, Angela M, Reid, Ian, Rojeski, Maria, Vanderkelen, Mark, Yang, Wenjing, Santiago, Norma Ruiz, Oates, Mary
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Bone and Mineral Metabolism
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207955/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.050
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items